Funded Tech Companies
LEXEO Therapeutics
Researching who provided funding to LEXEO Therapeutics? Alexandria Venture Investments, Invus and CAM Capital invested in this biopharmaceutical company.
Company Overview
Company Name
LEXEO Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
430 East 29th St. 14th Floor
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Website
Email Address
Company Background Information
Overview
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world's most devastating genetic and acquired diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/10/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nolan Townsend
Chief Medical Officer
Jay Barth
Chief Scientific Officer
Ronald Crystal
VP - Bus. Development
Christopher Holterhoff
VP - Operations
Paul McCormac
Company Investors
- Alexandria Venture Investments
- Invus
- CAM Capital
- Lundbeckfond Ventures (Mette Agger)
- Omega Funds (Bernard Davitian)
- Longitude Capital Management (Sandip Agarwala)
- PBM Capital
- D1 Capital Partners (Daniel Sundheim)
- Gray's Creek Capital Advisors
- Eventide Asset Management (Joy Ghosh)
- Woodline Partners
- Janus Henderson Investors
- Laurion Capital Management
- Verition Fund Management
- Alzheimer's Drug Discovery Foundation
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs